相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PI3KCA mutation status is of limited prognostic relevance in ER-positive breast cancer patients treated with hormone therapy
Lucia Veronica Cuorvo et al.
VIRCHOWS ARCHIV (2014)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types
Francisco Ferro de Beca et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
mTOR in breast cancer: Differential expression in triple-negative and non-triple-negative tumors
S. Walsh et al.
BREAST (2012)
Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers
Rachael Natrajan et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
mTOR Activation Induces Tumor Suppressors that Inhibit Leukemogenesis and Deplete Hematopoietic Stem Cells after Pten Deletion
Jae Y. Lee et al.
CELL STEM CELL (2010)
Immunohistochemical study of PTEN and phosphorylated mTOR proteins in familial and sporadic invasive breast carcinomas
Panagiotis Bakarakos et al.
HISTOPATHOLOGY (2010)
A novel signaling network as a critical rheostat for the biology and maintenance of the normal stem cell and the cancer-initiating cell
Keisuke Ito et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)
Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
Richard M. Simon et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Molecular mechanisms of mTOR-mediated translational control
Xiaoju Max Ma et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Efficacy of everolimus in advanced renal cell carcinoma:: a double-blind, randomised, placebo-controlled phase III trial
Robert J. Motzer et al.
LANCET (2008)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
Gary Hudes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Reuben J. Shaw et al.
NATURE (2006)
The Akt pathway in human breast cancer: a tissue-array-based analysis
S Bose et al.
MODERN PATHOLOGY (2006)
Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers
XY Zhou et al.
CLINICAL CANCER RESEARCH (2004)
Targeting mTOR signaling for cancer therapy
S Huang et al.
CURRENT OPINION IN PHARMACOLOGY (2003)
分享论文
